Related Experiment Videos
[Insulin sensitizers]
1Université de Liège, Service de Diabétologie, Nutrition et Maladies métaboliques, Département de Médecine.
Revue Medicale De Liege
|July 23, 2005
Summary
Insulin resistance, influenced by lifestyle and genetics, increases cardiovascular risk. Lifestyle changes and medications like metformin can improve outcomes and prevent type 2 diabetes.
Area of Science:
- Endocrinology and Metabolism
- Cardiovascular Health
Context:
- Insulin resistance is a key factor in metabolic syndrome and type 2 diabetes.
- It is influenced by genetic predisposition, diet, physical activity, and obesity.
- Insulin resistance significantly elevates cardiovascular disease risk.
Purpose:
- To explore the multifaceted nature of insulin resistance.
- To discuss its triggers, consequences, and management strategies.
- To highlight the importance of targeting insulin resistance for improved patient outcomes.
Summary:
- Insulin resistance, with a genetic basis, is exacerbated by lifestyle factors like poor diet and inactivity, leading to increased blood glucose and metabolic syndrome.
- It stresses pancreatic beta cells and is a major cardiovascular risk factor.
- Management involves lifestyle modifications and pharmacotherapy, including metformin and thiazolidinediones, with ongoing development of novel agents like PPAR agonists.
Impact:
- Effective management of insulin resistance can reduce hyperglycemia in type 2 diabetes.
- It aids in preserving beta-cell function, potentially preventing diabetes onset in at-risk individuals.
- Targeting insulin resistance improves metabolic health and significantly enhances cardiovascular prognosis.